-
Expert Insights: New Targets, New Agents, New Combinations: Navigating the New Landscape in Relapsed/Refractory Multiple Myeloma_Noopur Raje, MD_Joseph Mikhael, MD, MEd, FRCPC, FACP
29:13
-
Virtual Challenging Case Clinic: Multiple Myeloma_Updates from ASCO and EHA_Jonathan Kaufman, MD
54:43
-
Clinical Experience With Newly Approved Therapies_Joseph Mikhael, MD, MEd, FRCPC, FACP #ASCO21
21:43
-
Choosing the Right Combination Therapy_Krina Patel, MD, MSc #ASCO21
19:41
-
How to Manage Novel AE Patients_Noopur Raje, MD, Joseph Mikhael, MD, MEd, FRCPC, FACP, Krina Patel, MD, MSc #ASCO21
28:34
-
Evolving Profile of a Patient with Relapsed/Refractory MM_Noopur Raje, MD #ASCO21
9:41
-
Panel Discussion and Q&A_Noopur Raje, MD, Joseph Mikhael, MD, MEd, FRCPC, FACP, Krina Patel, MD, MSc #ASCO21
19:30
-
Shaji Kumar, MD; Mayo Clinic Rochester, MN; 5Live; #ASCO2021
6:09
-
Robert Orlowski, MD, PhD; The University of Texas MD Anderson Cancer Center; 5Live; #ASCO2021
4:48
-
Ravi Vij, MD, MBA; Washington University School of Medicine; 5Live; #ASCO2021
3:55
-
Nikhil Munshi, MD; Dana-Farber Cancer Institute at Harvard Medical School; 5Live; #ASCO2021
11:18
- Next Page
